BBC Future profiles MAPS Founder Rick Doblin, Ph.D., in an extensive article exploring the international impact of psychedelics on science, drug policy, culture, and medicine.
By highlighting the rapid increase in psychedelic research over the past ten years, Ed Prideaux of BBC explains how clinical trial results, favorable media coverage, and the potential development of new mental health treatments are steadily moving the public perception of psychedelics toward mainstream acceptance.
"Now the efforts of Doblin and others are finally paying off,” writes Prideaux. "Promising clinical trials suggest that psychedelics may prove game-changing treatments for depression, PTSD and addiction."
Read moreYale scientists have found that a single dose of psilocybin given to mice induces a rapid and long-lasting increase in connections between pyramidal neurons in the medial frontal cortex, an area of the brain known to be involved in control and decision-making.
Read moreContemplating a psychedelic “trip”?
Here is all you need to know about two of your options: Psilocybin vs. DMT.
Read moreHow Psychedelic Drugs Are Making a Comeback to Treat Depression
The hallucinogenic compound psilocybin is undergoing a renaissance-not as a recreational drug but as a potential treatment for mental health conditions. This podcast follows the journey of one participant of a scientific study into the psychedelic drug's effect on depression.
Read moreIn a new “astromycological” venture launched in conjunction with NASA, mycologist Paul Stamets and various research teams are studying how fungi can be leveraged to build extraterrestrial habitats and perhaps someday even terraform planets.
Read moreThe film Fantastic Fungi is now available on Netflix… check it out!
Read morePsychedelic users say that even bad trips gave them ‘life-altering insights’, a small study finds.
Read more